Related Experiment Video
Updated: May 17, 2026

09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
Gene networks: dissecting pathways in retinal development and disease
Cheryl Y Gregory-Evans1, Valerie A Wallace, Kevin Gregory-Evans
1Department of Ophthalmology, University of British Columbia, Vancouver, BC V5Z 3N9, Canada. cge30@mail.ubc.ca
Progress in Retinal and Eye Research
|November 7, 2012
Summary
Retinal development involves complex gene networks that control cell fate. Understanding these networks offers new therapeutic targets for retinal diseases.
Area of Science:
- Developmental biology
- Genetics
- Neuroscience
Background:
- Retinal neurogenesis generates diverse cell types in a specific spatial and temporal pattern.
- Cell fate and differentiation are regulated by transcription factors and signaling molecules.
- Gene network analysis is a key tool for understanding these complex regulatory mechanisms.
Purpose of the Study:
- To review current knowledge of gene networks in retinal development.
- To explore the implications of these networks for future retinal disease therapeutics.
- To highlight the role of transcriptional hubs in identifying therapeutic targets.
Main Methods:
- Review of existing literature on retinal development gene networks.
- Analysis of data from targeted gene deletion and gain-of-function experiments.
- Focus on gene network analysis to understand functional relationships.
Main Results:
- Gene networks are crucial for establishing the retina's laminar and mosaic architecture.
- Transcriptional hubs within these networks are identified as key regulatory points.
- These hubs suggest potential pathways for therapeutic intervention in retinal diseases.
Conclusions:
- Gene network analysis provides critical insights into retinal development.
- Understanding these networks is essential for developing novel therapeutic strategies for retinal diseases.
- Future research should focus on leveraging gene networks for targeted therapies.